U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
108031108031Efficacy and Safety of Cyclobenzaprine Hydrochloride Extended Release for the Treatment of Chronic MigraineTerminatedNo Results AvailableChronic MigraineDrug: cyclobenzaprine hydrochloride|Drug: placebohttps://ClinicalTrials.gov/show/NCT01151787
108032108032Validation of Transesophageal Echocardiography (TEE) to Measure Renal Resistive Index and to Predict Renal InjurySuspendedNo Results AvailableDecreased Vascular Flow to Kidneyshttps://ClinicalTrials.gov/show/NCT01151774
108033108033PII of SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver TransplantationTerminatedNo Results AvailableCholangiocarcinoma|Hepatobiliary Neoplasm|Liver Cancer|Bile Duct Cancer|Cancer of GallbladderProcedure: Stereotactic Body Radiotherapy|Drug: Gemcitabine100 mg/m2|Drug: Cisplatin|Drug: Carboplatin|Drug: Capecitabine|Drug: 5FUhttps://ClinicalTrials.gov/show/NCT01151761
108034108034Intra-arterial Chemotherapy for Advanced Intraocular RetinoblastomaWithdrawnNo Results AvailableRetinoblastoma|Eye CancerProcedure: Intra-arterial infusion of chemotherapyhttps://ClinicalTrials.gov/show/NCT01151748
108035108035C1-INH Compared to Placebo at the Time of Prodromal Symptoms for Hereditary Angioedema (HAE) ExacerbationWithdrawnNo Results AvailableHereditary AngioedemaDrug: C-1-esterase|Drug: C-1-esterase|Drug: placebohttps://ClinicalTrials.gov/show/NCT01151735
108036108036Adjuvant Intravitreal Bevacizumab in Pars Plana Vitrectomy for Diabetic Vitreous HemorrhageRecruitingNo Results AvailableRecurrent|HemorrhageProcedure: bevacizumab injection|Procedure: bevacizumab injectionhttps://ClinicalTrials.gov/show/NCT01151722
108037108037Assessment of Primary Care Providers' Knowledge and Beliefs Regarding Gout ManagementCompletedNo Results AvailableGouthttps://ClinicalTrials.gov/show/NCT01151709
108038108038Pain and Anxiety Management of Traumatic Emergency in a Pre-hospital SettingCompletedNo Results AvailablePainDrug: Atarax (Hydroxyzine)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01151696
108039108039Effects of Magnesium Supplementation on Vascular Structure and Function in Hypertensive PatientsCompletedNo Results AvailableHypertension|Endothelial DysfunctionDietary Supplement: magnesium|Dietary Supplement: placebohttps://ClinicalTrials.gov/show/NCT01151683
108040108040Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain TumorsCompletedNo Results AvailableBrain Neoplasms, Malignant|Brain Neoplasms, Benign|Malignant Meningioma|Glioblastoma Multiforme|Anaplastic AstrocytomaDrug: pioglitazone|Drug: Pioglitazonehttps://ClinicalTrials.gov/show/NCT01151670
108041108041Probiotics for Irritable Bowel SyndromeCompletedNo Results AvailableIrritable Bowel SyndromeDietary Supplement: Probiotics|Dietary Supplement: Placebohttps://ClinicalTrials.gov/show/NCT01151657
108042108042Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic DiseasesActive, not recruitingNo Results AvailableRheumatoid Arthritis|Spondyloarthritis|Systemic Lupus Erythematosus (SLE)|Dermatomyositis (DM)|DMixed Connective Tissue Disease|Systemic Vasculitis|Systemic Sclerosis (SSc)|Sjögren's Syndrome|Antiphospholipid Syndrome|Juvenile Idiopathic Arthritis|JuveniBiological: Anti-pandemic H1N1 influenza vaccinehttps://ClinicalTrials.gov/show/NCT01151644
108043108043Occipital Nerve Stimulation in Medically Intractable Chronic Cluster HeadacheRecruitingNo Results AvailableChronic Cluster HeadacheDevice: occipital nerve stimulationhttps://ClinicalTrials.gov/show/NCT01151631
108044108044[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT01151618
108045108045The Suppression of Toll Like Receptors by InsulinActive, not recruitingNo Results AvailableInsulin ResistanceDrug: insulin|Drug: insulin|Drug: insulinhttps://ClinicalTrials.gov/show/NCT01151605
108046108046Safety Assessment of Iron Sucrose (Venofer) in Patients With Chronic Kidney Disease Who Cannot Tolerate Ferumoxytol (Feraheme) or Iron Dextran (INFed or Dexferrum)WithdrawnNo Results AvailableIron Deficiency AnemiaDrug: Iron Sucrosehttps://ClinicalTrials.gov/show/NCT01151592
108047108047Effect of Nebulized Bronchodilators on Heart RateCompletedNo Results AvailableCOPD|CABG Surgery|Sepsis|Shock|Ventilators, MechanicalDrug: Levalbuterol|Drug: Albuterolhttps://ClinicalTrials.gov/show/NCT01151579
108048108048Can Ultrasound Replace Computed Tomography (CT) Scan in Those Unable to Have Computed Tomography (CT) Contrast AgentsCompletedNo Results AvailableNephrotoxicity of CT Contrast Agents|CT Scans in Those With Renal Compromise|Sensitivity to CT Contrast Agents|US With CEUS as Replacement for Unenhanced CT Scanhttps://ClinicalTrials.gov/show/NCT01151566
108049108049Oxidative Stress Markers and Cardiac Resynchronization Therapy (CRT) OutcomesTerminatedHas ResultsCongestive Heart FailureDevice: CRT Therapyhttps://ClinicalTrials.gov/show/NCT01151553
108050108050A Long Term Extension Study of E2080 in Lennox-Gastaut PatientsCompletedNo Results AvailableLennox-Gastaut SyndromeDrug: E2080https://ClinicalTrials.gov/show/NCT01151540
108051108051Peripheral Blood Biomarkers in Idiopathic Interstitial PneumoniasTerminatedNo Results AvailableIdiopathic Interstitial Pneumoniashttps://ClinicalTrials.gov/show/NCT01151527
108052108052Referral Patterns for Hospital Acquired Acute Kidney Injury and Relevance to Renal OutcomesCompletedNo Results AvailableRenal Replacement Therapy|MortalityOther: Nephrologist referralhttps://ClinicalTrials.gov/show/NCT01151514
108053108053Noninvasive Positive Pressure Ventilation for Early Extubation of Acute Hypoxemic Respiratory FailureNot yet recruitingNo Results AvailableAcute Hypoxemic Respiratory FailureDevice: noninvasive positive pressure ventilationhttps://ClinicalTrials.gov/show/NCT01151501
108054108054Nutrition, Exercise, and Breast Cancer SurvivorshipActive, not recruitingNo Results AvailableBreast Cancer Survivorship|SarcopeniaOther: Resistance Training|Other: Resistance Training + Nutritional Supplementationhttps://ClinicalTrials.gov/show/NCT01151488
108055108055Cerebral Oxygen, Blood Flow and Ammonia Uptake in Patients With Cirrhosis and an Acute Episode of Hepatic Encephalopathy (HE)CompletedNo Results AvailableLiver Cirrhosis|Hepatic Encephalopathyhttps://ClinicalTrials.gov/show/NCT01151475
108056108056Postnatal Human Cytomegalovirus (HCMV) Infection in Very Preterm Infants. Implications on Acute and Chronic Morbidity, Growth and Neurodevelopmental Outcomes. Part of the Study on "Nutrition, Growth and Development Among Very Preterm Infants"TerminatedNo Results AvailableNeurodevelopmental Disabilities|Hearing Loss|Mental Retardation|Microcephaly|Chorioretinitis|Growthhttps://ClinicalTrials.gov/show/NCT01151462
108057108057Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced, Metastatic, or Recurrent Triple Negative Invasive Breast CancerActive, not recruitingNo Results AvailableEstrogen Receptor-negative Breast Cancer|HER2-negative Breast Cancer|Male Breast Cancer|Progesterone Receptor-negative Breast Cancer|Recurrent Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer|Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01151449
108058108058Global Management of Facial Rejuvenation With a New Range of Hyaluronic Acid Dermal FillersCompletedHas ResultsFacial WrinklesDevice: hyaluronic acid dermal fillershttps://ClinicalTrials.gov/show/NCT01151436
108059108059Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)CompletedNo Results AvailableThrombotic Thrombocytopenic PurpuraBiological: anti-vWF Nanobody|Biological: Placebo|Other: Plasma exchangehttps://ClinicalTrials.gov/show/NCT01151423
108060108060An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of AgeCompletedNo Results AvailableHypertensionDrug: Aliskiren|Drug: Enalaprilhttps://ClinicalTrials.gov/show/NCT01151410

* Görseller ve İçerik tekif hakkına sahip olabilir